1. The novel index using preoperative C-reactive protein and neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with pancreatic cancer
   Tomohiko Taniai et al, 2021, International Journal of Clinical Oncology CrossRef
2. A Novel Prognostic Score Combining Preoperative Biliary Drainage and Inflammatory Status for Patients with Periampullary Cancers
   Yuki Fujiwara et al, 2020, Journal of Gastrointestinal Surgery CrossRef
3. C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation
   Tobias Meischl et al, 2019, PLOS ONE CrossRef
4. Portal Vein Thrombosis and Markers of Inflammation in Hepatocellular Carcinoma
   B.I. Carr et al, 2020, Journal of Gastrointestinal Cancer CrossRef
5. Innovative Blood Tests for Hepatocellular Carcinoma: Liquid Biopsy and Evaluation of Systemic Inflammatory Reaction
   Ilze Strumfa et al, 2018, Hepatocellular Carcinoma - Advances in Diagnosis and Treatment CrossRef
6. Links between Inflammation and Postoperative Cancer Recurrence
   Tomonari Kinoshita et al, 2021, Journal of Clinical Medicine CrossRef
7. The Comparison of Inflammation-Based Prognostic Scores in Patients With Extrahepatic Bile Duct Cancer After Pancreaticoduodenectomy
   Yuki Fujiwara et al, 2019, Journal of Surgical Research CrossRef
8. Preoperative controlling nutritional status (CONUT) score predicts long-term outcomes in patients with non-B non-C hepatocellular carcinoma after curative hepatic resection
   Masashi Tsunematsu et al, 2021, Langenbeck's Archives of Surgery CrossRef
9. Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinoma
   Hikmet Akkiz et al, 2021, International Journal of Clinical Practice CrossRef
10. A multi-parametric prognostic model based on clinical features and serological markers predicts overall survival in non-small cell lung cancer patients with chronic hepatitis B viral infection
    Shulin Chen et al, 2020, Cancer Cell International CrossRef
11. Glasgow Prognostic Score and modified Glasgow Prognostic Score and survival in patients with hepatocellular carcinoma: a meta-analysis
    Lingling Lu et al, 2021, BMJ Open CrossRef